SRC and lung cancer: This notion is supported by our observations that 1) Similar to ISL, Src specific inhibitor PP1 also blocked serum-induced cytoskeleton reorganization and focal adhesion assembly (Fig. 3b and Additional file 1: Figure S5); and 2) ISL diminished Tyr416-phosphorylation of Src in lung cancer cells (Fig. 3c).